CIK 0001048477 · Large accelerated filer
BIOMARIN PHARMACEUTICAL INC
Sign in to watch- Ticker
- BMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 680397820
- Phone
- 4155066700
- Business address
- 105 DIGITAL DRIVE, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,163,748
- in 1 filing
Net −$1,163,748. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-30 | Mueller Brian EVP, Chief Financial Officer | Option exercise · Stock Option (Right to Buy Common Stock) 10b5-1 | −5,000 | 0 | ||
| 2024-05-28 | Davis George Eric EVP, Chief Legal Officer | Option exercise 10b5-1 | +40,850 | $63.10 | $2.6M | 97,007 |
| 2024-05-28 | Davis George Eric EVP, Chief Legal Officer | Sale 10b5-1 | −38,071 | $74.46 | $2.8M | 58,936 |
| 2024-05-28 | Davis George Eric EVP, Chief Legal Officer | Sale 10b5-1 | −2,779 | $75.29 | $209K | 56,157 |
| 2024-05-28 | Davis George Eric EVP, Chief Legal Officer | Option exercise · Stock Option (Right to Buy Common Stock) 10b5-1 | −40,850 | 0 | ||
| 2024-05-21 | PYOTT DAVID E I Director | Grant or award | +4,720 | 49,750 | ||
| 2024-05-21 | MEIER RICHARD A Director | Grant or award | +7,080 | 119,627 | ||
| 2024-05-21 | HOMBACH ROBERT J. Director | Grant or award | +4,720 | 35,220 | ||
| 2024-05-21 | Ho Maykin Director | Grant or award | +4,720 | 21,360 | ||
| 2024-05-21 | HERON ELAINE J Director | Grant or award | +4,720 | 96,841 | ||
| 2024-05-21 | Enyedy Mark J Director | Grant or award | +4,720 | 6,900 | ||
| 2024-05-21 | Dere Willard H Director | Grant or award | +4,720 | 32,300 | ||
| 2024-05-21 | Countouriotis Athena Director | Grant or award | +4,720 | 6,900 | ||
| 2024-05-21 | Bodem Barbara W. Director | Grant or award | +4,720 | 6,900 | ||
| 2024-05-21 | ANDERSON ELIZABETH M Director | Grant or award | +4,720 | 27,800 | ||
| 2024-05-20 | Hubbard Cristin EVP, Chief Commercial Officer | Grant or award | +14,690 | 14,690 | ||
| 2024-05-20 | Hubbard Cristin EVP, Chief Commercial Officer | Grant or award | +4,700 | 19,390 | ||
| 2024-05-20 | Hubbard Cristin EVP, Chief Commercial Officer | Grant or award · Stock Option (Right to Buy Common Stock) | +33,520 | 33,520 | ||
| 2024-05-20 | BIENAIME JEAN JACQUES Director | Shares withheld for taxes | −1,202 | $77.05 | $93K | 473,792 |
| 2024-05-17 | Burkhart Erin GVP, Chief Accounting Officer | Shares withheld for taxes | −993 | $76.97 | $76K | 15,163 |
Page 7 of 10 · 187 trades